[go: up one dir, main page]

WO2000068397A1 - Biological tagatose production by recombinant escherichia coli - Google Patents

Biological tagatose production by recombinant escherichia coli Download PDF

Info

Publication number
WO2000068397A1
WO2000068397A1 PCT/KR1999/000661 KR9900661W WO0068397A1 WO 2000068397 A1 WO2000068397 A1 WO 2000068397A1 KR 9900661 W KR9900661 W KR 9900661W WO 0068397 A1 WO0068397 A1 WO 0068397A1
Authority
WO
WIPO (PCT)
Prior art keywords
tagatose
coli
galactose
recombinant
arabinose isomerase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR1999/000661
Other languages
French (fr)
Inventor
Pil Kim
Hoe-Jin Roh
Sang-Hyun Yoon
Jin-Hwan Choi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TONGYANG CONFECTIONERY CO
Original Assignee
TONGYANG CONFECTIONERY CO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TONGYANG CONFECTIONERY CO filed Critical TONGYANG CONFECTIONERY CO
Priority to EP99954465A priority Critical patent/EP1095153A1/en
Priority to AU10806/00A priority patent/AU1080600A/en
Publication of WO2000068397A1 publication Critical patent/WO2000068397A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90Isomerases (5.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/24Preparation of compounds containing saccharide radicals produced by the action of an isomerase, e.g. fructose

Definitions

  • the present invention relates to a novel recombinant E. coli, a fermentation process and a enzymatic conversion process for tagatose production using such recombinant E. ⁇ li harboring vector containing the gene of L-arabinose isomerase, and the promoter controlled artificially.
  • D-Tagatose is one of ketohexoses as well as one of D-galactose isomers. D-Tagatose is reported as the sweetener having the taste most similar to that of sucrose (92%). In addition, D-tagatose does not show laxative effect, which other polyols generally do. Due to such reasons, D-tagatose has been recently regarded as a non-caloric sweetener substituted by sucrose [Zehener, L. R., D-Tagatose as a low-calorie carbohydrate sugar and bulking agent, EP 257626 (1988) ; Marzur, A. W., Functional sugar substitutes with reduced calories, EP 341062 (1989)].
  • D-Galactose could be converted into D-tagatose in the presence of a calcium catalyst [Beadle, J. R., Saunders, J. P., and Wajda, T. J., Process for manufacturing tagatose, WO 92/12263 (1992)].
  • a calcium catalyst Beadle, J. R., Saunders, J. P., and Wajda, T. J., Process for manufacturing tagatose, WO 92/12263 (1992)
  • the chemical synthesis is economical, this process also requires disadvantageous high temperature and high pressure.
  • the biological process has been researched with interest as an environmentally clean process. As a consequence, the biological production of D-tagatose has been intensively studied recently.
  • L-arabinose isomerase (AraA) could convert galactose into tagatose.
  • Cheetham reported that L-arabinose isomerase from Mycobacterium and Lactobacillus catalyzes the conversion from D-galactose to D-tagatose as well as that of from L-arabinose to L-ribulose, because of the similar substrate configuration [Cheetham, P. S. J., and Wootton, A. N., "Byconversion of D-galactose into D-tagatose", Enzyme Microbiol. Technol, 15, 105-108 (1993)].
  • Enterobacter agglomerans could also produce tagatose from galactose during the growth on the arabinose pre-induced medium. Such implies the fact that arabinose isomerase could mediate the conversion of tagatose [Kim, S. Y., Roh, H. J., and Oh, D. K., "D-Tagatose production from D-galactose by Enterobacter agglomerans TY-25", Kor. ]. Appl. Microbiol. Biotechnol, 25, 490-494 (1997)].
  • the object of the present invention is to provide a recombinant E.coli having a new metabolic pathway for producing tagatose from galactose.
  • Another object of the present invention is to provide new method for tagatose production by using said recombinant E.coli.
  • the further object of the present invention is to provide a new method for tagatose production by using the L-arabinose isomerase originated from said recombinant E.coli.
  • the present invention relates to a recombinant E.coli (KCTC-0603BP) harboring vector comprising i ) the gene of L-arabinose isomerase (EC 5.3.1.4; araA) and ii ) the promoter controlled artificially (pTClOl) for tagatose production.
  • araA is originated from the group consisting of E.coli, Bacillus, Salmonella, Enterobacter, Klebsiella, Pseudomonas, Lactobacillus, Zymononas, Ghiconobacter, RJtizobium, Acetobacter, RJwdobacter, Agrobacterium, and other microorganisms. Further, araA is integrated into the host chromosome.
  • the another aspect of the present invention relates to a fermentation process for tagatose production wherein the medium comprises 10-300 g/L of galactose, 7-13 g/L of yeast extract, 2-4 g/L of KH 2 P0 4 5-7 g/L of Na 2 HP ⁇ 4 and 1-3 g/L of ammonium chloride.
  • L-arabinose isomerase from said strain mediates galactose to tagatose conversion.
  • the L-arabinose isomerase can be immobilized for the recycle.
  • the conversion medium comprises 10-500 g/L of galactose, 2-4 g/L of KH2PO 4 , and 5-7 g/L of Na 2 HP0 4 .
  • Fig. 1 is a chemical structure of D-tagatose and D-galactose.
  • Fig. 2 is a schematic diagram of bioconversion by L-arabinose isomerase.
  • Fig. 3 is a photograph which represents PCR product of L-arabinose isomerase from E.coli. Arrow indicates the PCR product of Ara A from E.coli (1.5 kb). Lane 1 shows the size marker (lkb DNA Ladder, NEB, USA).
  • Fig. 4 is a plasmid map of pTClOl, which harboring L-arabinose isomerase.
  • Fig. 5 is a photograph which represents EcoRl-Hindl ⁇ double digest of pTClOl. Arrow indicates the pTClOl. Lane 1 shows the size marker (lkb DNA Ladder, NEB, USA).
  • Fig. 6 is a profile of tagatose production by purified L-arabinose isomerase.
  • D-Tagatose is a potential bulking agent in food as a non-caloric sweetener.
  • plasmids harboring the L-arabinose isomerase gene (araA) from Esdierichia coli is constructed because L-arabinose isomerase has been suggested as an enzyme that mediates the bioconversion of galactose to tagatose as well as that of arabinose to ribulose.
  • the constructed plasmids has been named as pTClOl, which contains the araA from E.coli.
  • tagatose has been produced from galactose in 9.0—11.0 % yields.
  • the purified L-arabinose isomerase of E.coli with the plasmid pTClOl has also produced 25—35 g/L of tagatose from 100 g/L of galactose for 150 —180 hours bioconversion.
  • the enzyme extract of E.coli with the plasmid pTClOl has been immobilized into alginate bead. By using an immobilized enzyme system, 11 —14 g/L of tagatose has been produced from 10 % galactose for 24 hours.
  • E.coli is a Gram negative facultative anaerobic rod-form bacteria [Holt J. G., et. al, Bergey's Manual of Systematic Bacteriology 9th ed., 179, Williams & Wilkins (1994)]. It shows simple nutrient requirement, fast life cycle (about 20 min) in the optimal condition (pH 7.0, 37°C) [Stanier R. Y., et. al, The Microbiol World, 5th ed., 439 - 452(1986)].
  • E.coli is the most well known organism in physiology and genetics. Therefore, metabolism of E.coli can be easily controlled by the methods of genetic engineering and metabolic engineering.
  • the gene of L-arabinose isomerase (araA) of E.coli W3110 has been cloned by using a PCR technique, inserted into vector pKK223-3, which yields pTClOl.
  • the constructed plasmids harboring araA from E.coli has been used to transform E.coli JM105 (E.coli JM105/pTC101).
  • ImM IPTG was added to medium.
  • AraA L-Arabinose isomerase
  • the normal E.coli does not express AraA in the medium for tagatose production because the medium contains galactose as a sole carbon source.
  • the AraA could be artificially induced by adding an IPTG.
  • E.coli JM105/pTC101 was deposited in Korean Collection for Type Cultures in Korea Research Institute of Bioscience and Bioengineering, in accession number of KCTC-0603BP on April 26, 1999 under Budapest Treaty.
  • Step 1 PCR cloning of araA and Insertion into Expression Vector
  • the template for PCR of araA was chromosome of a wild type E.coli W3110 [Genetic stock center collection number (CGSC) 4474],
  • the each primer used in PCR contained the part of araA terminal sequence and restriction enzyme site (EcoRI and Hi ⁇ rflll, respectively).
  • FORWARD 5'-GACGAATTCATGACGATT-3' (SEQ ID NO. 1)
  • BACKWARD 5'-TGCAAGCTTTTAGCGACG-3' (SEQ ID NO. 2)
  • PCR product sequence (SEQ ID NO. 3) is as follows.
  • the constructed plasmid was transformed into E.coli JM105 [Roh, H. J., Kim, P., Park Y. C, and Choi, J. H., Biotechnol and Appl. Biochem., BA99/65, in press] (Fig.4).
  • Step 2 Strain Selection
  • the transformed strains were selected on the plate containing ampicillin (50g/ml) on the base of ampicillin-resistance. The colonies were further confirmed by restriction enzyme which digests the harbored plasmids, which shows 1.5 kb + 4.5 kb DNA fragments at the time of digestion by EcoRI and HmdIII (Fig. 5). The finally selected strain was named as E.coli JM105/pCT101, and said E.coli JM105/pTC101 was deposited in Korean Collection for Type Cultures in Korea Research Institute of Bioscience and Bioengineering, in accession number of KCTC-0603BP on April 26, 1999 under Budapest Treaty.
  • the E.coli JM105/pTC101 was pre-cultured in the LB-medium, and then transferred into main culture medium.
  • the main medium contained following components (Table 1).
  • Tagatose and galactose were estimated by using a HPLC (alliance 2690, Waters, USA) with RI detector (RID410, Waters, USA). The separation was made by C18-amine column (KR100-10NH 2 , Kromasil, Bohus, Sweden) eluted isocratically by 80% acetonitrile (35°C, 2 ml/min).
  • recombinant E.coli expressing L-arabinose isomerase could convert galactose into tagatose, where control strain could not.
  • a crude extract of AraA from E.coli was prepared as follows. Actively growing cells (50 ml, O.D. 600 2.0) in the LB-medium containing IPTG (1 mM) were prepared by centrifugation (7,000 g, 4°C). The cell pellet was resuspended in a 5 ml of phosphate buffer (50 mM, pH 7.0). The cells were disrupted by using an ultrasonic processor (50-watt Model, Cole-Parmer) at 40% output for 10 min in the ice. The crude arabinose isomerase solution was obtained after removal of cell-debris by centrifugation of the cell-disrupted suspension at 7,000 g and 4"C for 15 min.
  • a crude extract of AraA was fractionated by ammonium sulfate salting out at 40-60% saturation, and pelleted by centrifuge (10,000g, 4°C). The pellet was further dialyzed overnight at 4°C using a cellulose membrane tubing (MWCO : 12,000, Sigma, USA) to remove ammonium sulfate. Column chromatography was further carried out using DEAE (Sigma, USA) and Q-Sepharose (Sigma, USA) as anion exchange resins. The final purified L-arabinose isomerase showed 43 U/ml, where one unit defined as the amount of enzyme which produced 1 g-tagatose per minute at 35 °C, pH 7.0.
  • the reaction mixtures consisted of 9 ml of galactose (1 g) dissolved in 50mM phosphate buffer (pH 7.0) and 1 ml of enzyme solution mentioned the above.
  • the bioconversion for tagatose production was performed at 35 °C, pH 7.0 for 168 hrs. As shown in Fig. 6, the final tagatose concentration was reached 29.5 g/L. Remained galactose was 70.5 g/L.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

This invention relates to a recombinant Escherichia coli and a process for producing D-tagatose. In detail, it includes the construction of recombinant E.coli harboring L-arabinose isomerase, whole-cell conversion of D-galactose into D-tagatose by recombinant E.coli expressing L-arabinose isomerase, enzymatic production of D-tagatose by the extract of recombinant E.coli expressing L-arabinose isomerase, and bioconversion by immobilized L-arabinose isomerase.

Description

Biological Tagatose Production by Recombinant Escheridiia coli
TECHNICAL FIELD
The present invention relates to a novel recombinant E. coli, a fermentation process and a enzymatic conversion process for tagatose production using such recombinant E. ωli harboring vector containing the gene of L-arabinose isomerase, and the promoter controlled artificially.
BACKGROUND ART
D-Tagatose is one of ketohexoses as well as one of D-galactose isomers. D-Tagatose is reported as the sweetener having the taste most similar to that of sucrose (92%). In addition, D-tagatose does not show laxative effect, which other polyols generally do. Due to such reasons, D-tagatose has been recently regarded as a non-caloric sweetener substituted by sucrose [Zehener, L. R., D-Tagatose as a low-calorie carbohydrate sugar and bulking agent, EP 257626 (1988) ; Marzur, A. W., Functional sugar substitutes with reduced calories, EP 341062 (1989)].
Several methods have been studied for the manufacture of D-tagatose. D-Galactose could be converted into D-tagatose in the presence of a calcium catalyst [Beadle, J. R., Saunders, J. P., and Wajda, T. J., Process for manufacturing tagatose, WO 92/12263 (1992)]. Although the chemical synthesis is economical, this process also requires disadvantageous high temperature and high pressure. Recently, the biological process has been researched with interest as an environmentally clean process. As a consequence, the biological production of D-tagatose has been intensively studied recently.
Among the such studies, D-tagatose production from galactitol using galactitol dehydrogenase has been well known [Izumori, K., and Keiji, T., "Production of D-tagatose from D-galactitol by Mycobacterium smegmatis", J. Ferment. Technol, 15, 105-108 (1988) ; Shimonish, T., Okumura, Y., Izumori, K. "Production of L-tagatose from galactitol by Klebsiella pneumoniae strain 40b", /. Ferment. Bioeng., 79, 620-622 (1995)]. Galactitol, however, is more expensive than galactose and seems to be that the commercial application of galactitol is only a little potential.
It has been suggested that L-arabinose isomerase (AraA) could convert galactose into tagatose. Cheetham reported that L-arabinose isomerase from Mycobacterium and Lactobacillus catalyzes the conversion from D-galactose to D-tagatose as well as that of from L-arabinose to L-ribulose, because of the similar substrate configuration [Cheetham, P. S. J., and Wootton, A. N., "Byconversion of D-galactose into D-tagatose", Enzyme Microbiol. Technol, 15, 105-108 (1993)]. Enterobacter agglomerans could also produce tagatose from galactose during the growth on the arabinose pre-induced medium. Such implies the fact that arabinose isomerase could mediate the conversion of tagatose [Kim, S. Y., Roh, H. J., and Oh, D. K., "D-Tagatose production from D-galactose by Enterobacter agglomerans TY-25", Kor. ]. Appl. Microbiol. Biotechnol, 25, 490-494 (1997)].
DISCLOSURE OF INVENTION
The object of the present invention is to provide a recombinant E.coli having a new metabolic pathway for producing tagatose from galactose.
Another object of the present invention is to provide new method for tagatose production by using said recombinant E.coli.
The further object of the present invention is to provide a new method for tagatose production by using the L-arabinose isomerase originated from said recombinant E.coli. Further, the present invention relates to a recombinant E.coli (KCTC-0603BP) harboring vector comprising i ) the gene of L-arabinose isomerase (EC 5.3.1.4; araA) and ii ) the promoter controlled artificially (pTClOl) for tagatose production. In said recombinant E.coli, araA is originated from the group consisting of E.coli, Bacillus, Salmonella, Enterobacter, Klebsiella, Pseudomonas, Lactobacillus, Zymononas, Ghiconobacter, RJtizobium, Acetobacter, RJwdobacter, Agrobacterium, and other microorganisms. Further, araA is integrated into the host chromosome.
The another aspect of the present invention relates to a fermentation process for tagatose production wherein the medium comprises 10-300 g/L of galactose, 7-13 g/L of yeast extract, 2-4 g/L of KH2P04 5-7 g/L of Na2HPθ4 and 1-3 g/L of ammonium chloride. Further, L-arabinose isomerase from said strain mediates galactose to tagatose conversion. On the other hand, the L-arabinose isomerase can be immobilized for the recycle. At this time, the conversion medium comprises 10-500 g/L of galactose, 2-4 g/L of KH2PO4, and 5-7 g/L of Na2HP04.
BRIEF DESCRIPTION OF THE DRAWINGS
Fig. 1 is a chemical structure of D-tagatose and D-galactose.
Fig. 2 is a schematic diagram of bioconversion by L-arabinose isomerase.
Fig. 3 is a photograph which represents PCR product of L-arabinose isomerase from E.coli. Arrow indicates the PCR product of Ara A from E.coli (1.5 kb). Lane 1 shows the size marker (lkb DNA Ladder, NEB, USA).
Fig. 4 is a plasmid map of pTClOl, which harboring L-arabinose isomerase.
Fig. 5 is a photograph which represents EcoRl-Hindlϊ double digest of pTClOl. Arrow indicates the pTClOl. Lane 1 shows the size marker (lkb DNA Ladder, NEB, USA).
Fig. 6 is a profile of tagatose production by purified L-arabinose isomerase.
BEST MODE FOR CARRYING OUT THE INVENTION
D-Tagatose is a potential bulking agent in food as a non-caloric sweetener. To produce D-tagatose from cheaper resources, plasmids harboring the L-arabinose isomerase gene (araA) from Esdierichia coli is constructed because L-arabinose isomerase has been suggested as an enzyme that mediates the bioconversion of galactose to tagatose as well as that of arabinose to ribulose. The constructed plasmids has been named as pTClOl, which contains the araA from E.coli. During the cultivation of recombinant E.coli with pTClOl, tagatose has been produced from galactose in 9.0—11.0 % yields.
The purified L-arabinose isomerase of E.coli with the plasmid pTClOl has also produced 25—35 g/L of tagatose from 100 g/L of galactose for 150 —180 hours bioconversion. The enzyme extract of E.coli with the plasmid pTClOl has been immobilized into alginate bead. By using an immobilized enzyme system, 11 —14 g/L of tagatose has been produced from 10 % galactose for 24 hours.
This invention includes the application of recombinant E.coli. The characteristics of E.coli are as follows. E.coli is a Gram negative facultative anaerobic rod-form bacteria [Holt J. G., et. al, Bergey's Manual of Systematic Bacteriology 9th ed., 179, Williams & Wilkins (1994)]. It shows simple nutrient requirement, fast life cycle (about 20 min) in the optimal condition (pH 7.0, 37°C) [Stanier R. Y., et. al, The Microbiol World, 5th ed., 439 - 452(1986)].
In addition to the above characteristics, E.coli is the most well known organism in physiology and genetics. Therefore, metabolism of E.coli can be easily controlled by the methods of genetic engineering and metabolic engineering.
There are no direct evidences about the enzyme involving in the isomerization reaction of galactose to tagatose in E.coli. Kim et al, however, reported that Enterobacter induced by arabinose produces tagatose from galactose substrate [Kim, S. Y., Roh, H. J., and Oh, D. K., D-Tagatose Production from Galactose by Entevbacter agglomerans TY-25, Kor. J. Appl. Microbiol. BiotechnoL, 25, 490-494 (1997)], which implicates that some enzyme(s) induced by arabinose can convert galactose into tagatose. Cheetham and Wootton suggested that arabinose isomerase of Lactobaάllus had a potential to convert galactose into tagatose [Cheetham and Wootton., Bioconversion of D-galactose into D-tagatose, Enzyme Microbiol. Technol, 15, 105-108 (1993)].
Based on the above reports, the gene of L-arabinose isomerase (araA) of E.coli W3110 has been cloned by using a PCR technique, inserted into vector pKK223-3, which yields pTClOl. The constructed plasmids harboring araA from E.coli has been used to transform E.coli JM105 (E.coli JM105/pTC101). For the expression of AraA, ImM IPTG was added to medium.
L-Arabinose isomerase (AraA) is an enzyme mediating the conversion of arabinose to ribulose, which is induced by arabinose and inhibited by glucose. It have been suggested AraA could mediate galactose to tagatose with low efficiency because of the substrate similarity between arabinose and galactose (Fig. 2) [Cheetham and Wootton., Bioconversion of D-galactose into D-tagatose, Enzyme Microb. Technol, 15, 105-108 (1993)].
The normal E.coli does not express AraA in the medium for tagatose production because the medium contains galactose as a sole carbon source. In the case of E.coli JM105/pTC101, the AraA could be artificially induced by adding an IPTG.
Said E.coli JM105/pTC101 was deposited in Korean Collection for Type Cultures in Korea Research Institute of Bioscience and Bioengineering, in accession number of KCTC-0603BP on April 26, 1999 under Budapest Treaty.
The present invention will be more specifically explained by the following examples. However, it should be understood that the examples are intended to illustrate but not in any manner to limit the scope of the present invention.
EXAMPLE 1
Construction of Recombinant E.coli Harboring Arabinose Isomerase Gene
Construction of recombinant E.coli was followed by Sambrook method [Sambrook et al, Molecular Cloning : A Laboratory Manual 2nd Ed., Cold Spring Harbor Laboratory Press (1989)].
Step 1 : PCR cloning of araA and Insertion into Expression Vector
The template for PCR of araA was chromosome of a wild type E.coli W3110 [Genetic stock center collection number (CGSC) 4474], The each primer used in PCR contained the part of araA terminal sequence and restriction enzyme site (EcoRI and Hiπrflll, respectively).
FORWARD 5'-GACGAATTCATGACGATT-3' (SEQ ID NO. 1) BACKWARD 5'-TGCAAGCTTTTAGCGACG-3' (SEQ ID NO. 2)
As the above result, 1.5 kb of DNA fragment was obtained (Fig. 3). The obtained PCR product (1.5 kb) was ligated into expression vector, pKK223-3 (4.5 kb, Pharmacia, Uppsala, Sweden), after doulbe digest by EcoRl-Hindϊll restriction enzyme. The PCR product sequence (SEQ ID NO. 3) is as follows.
atgacgattt ttgataatta tgaagtgtgg tttgtcattg gcagccagca tctgtatggc 60 ccggaaaccc tgcgtcaggt cacccaacat gccgagcacg tcgttaatgc gctgaatacg 120 gaagcgaaac tgccctgcaa actggtgttg aaaccgctgg gcaccacgcc ggatgaaatc 180 accgctattt gccgcgacgc gaattacgac gatcgttgcg ctggtctggt ggtgtggctg 240 cacaccttct ccccggccaa aatgtggatc aacggcctga ccatgctcaa caaaccgttg 300 ctgcaattcc acacccagtt caacgcggcg ctgccgtggg acagtatcga tatggacttt 360 atgaacctga accagactgc acatggcggt cgcgagttcg gcttcattgg cgcgcgtatg 420 cgtcagcaac atgccgtggt taccggtcac tggcaggata aacaagccca tgagcgtatc 480 ggctcctgga tgcgtcaggc ggtctctaaa caggataccc gtcatctgaa agtctgccga 540 tttggcgata acatgcgtga agtggcggtc accgatggcg ataaagttgc cgcacagatc 600 aagttcggtt tctccgtcaa tacctgggcg gttggcgatc tggtgcaggt ggtgaactcc 660 atcagcgacg gcgatgttaa cgcgctggtc gatgagtacg aaagctgcta caccatgacg 720 cctgccacac aaatccacgg caaaaaacga cagaacgtgc tggaagcggc gcgtattgag 780 ctggggatga agcgtttcct ggaacaaggt ggcttccacg cgttcaccac cacctttgaa 840 gatttgcacg gtctgaaaca gcttcctggt ctggccgtac agcgtctgat gcagcagggt 900 tacggctttg cgggcgaagg cgactggaaa actgccgccc tgcttcgcat catgaaggtg 960 atgtcaaccg gtctgcaggg cggcacctcc tttatggagg actacaccta tcacttcgag 1020 aaaggtaatg acctggtgct cggctcccat atgctggaag tctgcccgtc gatcgccgca 1080 gaagagaaac cgatcctcga cgttcagcat ctcggtattg gtggtaagga cgatcctgcc 1140 cgcctgatct tcaataccca aaccggccca gcgattgtcg ccagcttgat tgatctcggc 1200 gatcgttacc gtctactggt taactgcatc gacacggtga aaacaccgca ctccctgccg 1260 aaactgccgg tggcgaatgc gctgtggaaa gcgcaaccgg atctgccaac tgcttccgaa 1320 gcgtggatcc tcgctggtgg cgcgcaccat accgtcttca gccatgcact gaacctcaac 1380 gatatgcgcc aattcgccga gatgcacgac attgaaatca cggtgattga taacgacaca 1440 cgcctgccag cgtttaaaga cgcgctgcgc tggaacgaag tgtattacgg gtttcgtcgc 1500 taa 1503
The constructed plasmid, named pTClOl, was transformed into E.coli JM105 [Roh, H. J., Kim, P., Park Y. C, and Choi, J. H., Biotechnol and Appl. Biochem., BA99/65, in press] (Fig.4).
Step 2 : Strain Selection
The transformed strains were selected on the plate containing ampicillin (50g/ml) on the base of ampicillin-resistance. The colonies were further confirmed by restriction enzyme which digests the harbored plasmids, which shows 1.5 kb + 4.5 kb DNA fragments at the time of digestion by EcoRI and HmdIII (Fig. 5). The finally selected strain was named as E.coli JM105/pCT101, and said E.coli JM105/pTC101 was deposited in Korean Collection for Type Cultures in Korea Research Institute of Bioscience and Bioengineering, in accession number of KCTC-0603BP on April 26, 1999 under Budapest Treaty.
EXAMPLE 2
Tagatose Production by the Whole Cell of Recombinant E.coli
The E.coli JM105/pTC101 was pre-cultured in the LB-medium, and then transferred into main culture medium. The main medium contained following components (Table 1).
Table 1.
Figure imgf000010_0001
Single colony of E.coli JM105/pTC101 was inoculated into 3ml LB medium, and overnight cultured at 37 °C aerobically. The preculture was transferred into 250 ml Erlenmyer flask containing 50 ml of the IPTG (ImM) in LB medium. When biomass reached absorbance 1.0 at 600 nm, cells were collected by centrifuge and inoculated into 3 ml of main medium. The main culture was maintained for 96 hrs at 37 °C, 250 rpm shaking incubator. Finally, 0.86 g/L of tagatose was produced from recombinant E.coli whole cell, where no tagatose was found in the wild type E.coli. (Table 2).
Table 2.
Figure imgf000011_0001
Tagatose and galactose were estimated by using a HPLC (alliance 2690, Waters, USA) with RI detector (RID410, Waters, USA). The separation was made by C18-amine column (KR100-10NH2, Kromasil, Bohus, Sweden) eluted isocratically by 80% acetonitrile (35°C, 2 ml/min).
As shown in Table 2, recombinant E.coli expressing L-arabinose isomerase (KCTC-0603BP) could convert galactose into tagatose, where control strain could not.
EXAMPLE 3
Tagatose Production by Crude Extract of Recombinant E.coli Expressing AraA
A crude extract of AraA from E.coli was prepared as follows. Actively growing cells (50 ml, O.D. 600 2.0) in the LB-medium containing IPTG (1 mM) were prepared by centrifugation (7,000 g, 4°C). The cell pellet was resuspended in a 5 ml of phosphate buffer (50 mM, pH 7.0). The cells were disrupted by using an ultrasonic processor (50-watt Model, Cole-Parmer) at 40% output for 10 min in the ice. The crude arabinose isomerase solution was obtained after removal of cell-debris by centrifugation of the cell-disrupted suspension at 7,000 g and 4"C for 15 min. A crude extract of AraA was fractionated by ammonium sulfate salting out at 40-60% saturation, and pelleted by centrifuge (10,000g, 4°C). The pellet was further dialyzed overnight at 4°C using a cellulose membrane tubing (MWCO : 12,000, Sigma, USA) to remove ammonium sulfate. Column chromatography was further carried out using DEAE (Sigma, USA) and Q-Sepharose (Sigma, USA) as anion exchange resins. The final purified L-arabinose isomerase showed 43 U/ml, where one unit defined as the amount of enzyme which produced 1 g-tagatose per minute at 35 °C, pH 7.0.
The reaction mixtures consisted of 9 ml of galactose (1 g) dissolved in 50mM phosphate buffer (pH 7.0) and 1 ml of enzyme solution mentioned the above. The bioconversion for tagatose production was performed at 35 °C, pH 7.0 for 168 hrs. As shown in Fig. 6, the final tagatose concentration was reached 29.5 g/L. Remained galactose was 70.5 g/L.
EXAMPLE 4
Tagatose Production by Immobilized Enzyme of L-Arabinose Isomerase
The purified L-arabinose isomerase as above was immobilized by a Calcium- Alginate. Briefly, 10 ml of the purified enzyme solution (381 U/ml) was mixed with the 10 ml of 0.15 M NaCl containing high-viscosity alginate gel (2.4 %), then slowly expressed through a needle (id = 0.3 mm) in a dropwise fashion into a 100 mM CaCl2 solution. After instantaneous gelation, the beads were allowed to polymerize further for the period of 10 min in the CaCl2 solution. The beads were added into 50 ml of galactose (100 g/L) dissolved in 50 mM phosphate buffer (pH = 7.0). The conversion was performed for 24 hrs at 35 °C incubator. Table 3 shows the result.
Table 3.
Figure imgf000012_0001
As shown in the Table 3, free enzyme solution gave 21.2 g/L where immobilized one gave 12.3 g/L of tagatose. This result indicates there is a mass transfer bottleneck in the case of immobilized enzyme whereas no mass transfer inhibition in the case of free enzyme. Though the immobilized enzyme showed low activity in the tagatose production, it could be recycled by simple filtration while free enzyme could not.

Claims

WHAT IS CLAIMED IS :
1. A recombinant E.coli (KCTC-0603BP) harboring vector comprising i ) the gene of L-arabinose isomerase (EC 5.3.1.4; araA) and ii ) the promoter controlled artificially (pTClOl) for tagatose production.
2. The recombinant E.coli according to claim 1, wherein araA is originated from the group consisting of E.coli, Bacillus, Salmonella, Enterobacter, Klebsiella, Pseudomonas, Lactobacillus, Zymononas, Ghiconobacter, RJiizobium, Acetobacter, Rliodobactei; Agrobacterium, and other microorganisms.
3. The recombinant E.coli according to claim 1, wherein araA is integrated into the host chromosome.
4. A fermentation process for tagatose production using the whole cell of recombinant E.coli of claim 1.
5. The fermentation process for tagatose production according to claim 4, wherein the medium comprises 10-300 g/L of galactose, 7-13 g/L of yeast extract, 2-4 g/L of KH2Pθ4, 5-7 g/L of Na2HPθ4, and 1-3 g/L of ammonium chloride.
6. The enzymatic conversion process for tagatose production by L-arabinose isomerase, wherein the L-arabinose isomerase from strain of claim 1 mediates isomerization of galactose into tagatose.
7. The enzymatic conversion process for tagatose production according to claim 6, wherein the L-arabinose isomerase is immobilized for the recycle.
8. The enzymatic conversion process for tagatose production according to claim 6 or claim 7, wherein the conversion medium comprises 10-500 g/L of galactose, 2-4 g/L of KH2P04/ and 5-7 g/L of Na2HP04.
PCT/KR1999/000661 1999-05-06 1999-11-04 Biological tagatose production by recombinant escherichia coli Ceased WO2000068397A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP99954465A EP1095153A1 (en) 1999-05-06 1999-11-04 Biological tagatose production by recombinant escherichia coli
AU10806/00A AU1080600A (en) 1999-05-06 1999-11-04 Biological tagatose production by recombinant LTiGTescherichia coliLT/iGT

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR19990016118A KR100309327B1 (en) 1999-05-06 1999-05-06 Recombinant strain of Escherichia coli harboring Arabinose Isomerase and Tagatose Production Thereby
KR1999/16118 1999-05-06

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US09743196 A-371-Of-International 2001-01-08
US10/440,407 Continuation US20030235894A1 (en) 1999-05-06 2003-05-19 Biological tagatose production by recombinant Escherichia coli

Publications (1)

Publication Number Publication Date
WO2000068397A1 true WO2000068397A1 (en) 2000-11-16

Family

ID=19583888

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR1999/000661 Ceased WO2000068397A1 (en) 1999-05-06 1999-11-04 Biological tagatose production by recombinant escherichia coli

Country Status (4)

Country Link
EP (1) EP1095153A1 (en)
KR (1) KR100309327B1 (en)
AU (1) AU1080600A (en)
WO (1) WO2000068397A1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002052021A1 (en) * 2000-12-22 2002-07-04 Yu Ryang Pyun Thermostable l-arabinose isomerase and process for preparing d-tagatose thereby
WO2003008593A3 (en) * 2001-07-16 2003-10-30 Bioteknologisk Inst A thermostable isomerase and use thereof in particular for producing tagatose
US7052898B2 (en) 2001-07-16 2006-05-30 Bioneer A/S Thermostable isomerase and use hereof, in particular for producing tagatose
EP2348107A2 (en) 2003-02-18 2011-07-27 Metabolic Explorer Method for preparing evolved micro-organisms, enabling the creation or modification of metabolic pathways
US10570467B1 (en) 2016-09-27 2020-02-25 The Board Of Trustees Of The University Of Illinois Recombinant microorganisms for conversion of oligosaccharides into functional sweeteners
EP3578651A4 (en) * 2016-12-23 2021-01-13 Kyungpook National University Industry-Academic Cooperation Foundation Recombinant strain having modified sugar metabolic pathway and method for screening sugar isomerase using same

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100464061B1 (en) * 2002-05-15 2004-12-30 (주)케비젠 Tagatose production method by immobilization of arabinose isomerase
US8137946B2 (en) 2006-11-27 2012-03-20 Cj Cheiljedang Corporation Recombinant GRAS strains expressing thermophilic arabinose isomerase as an active form and method of preparing food grade tagatose by using the same
KR20100001209A (en) * 2008-06-26 2010-01-06 한국화학연구원 Method for preparing tagatose using microorganisms which galactose uptake are repressed
KR101015343B1 (en) 2008-08-05 2011-02-16 씨제이제일제당 (주) Arabinos isomerase variants with enhanced enzyme activity

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0552894A2 (en) * 1992-01-16 1993-07-28 Kraft Foods, Inc. D-tagatose production by enzymatic isomerization of D-galactose
JPH06113875A (en) * 1992-10-08 1994-04-26 Hayashibara Biochem Lab Inc Production of l-galactose

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0552894A2 (en) * 1992-01-16 1993-07-28 Kraft Foods, Inc. D-tagatose production by enzymatic isomerization of D-galactose
JPH06113875A (en) * 1992-10-08 1994-04-26 Hayashibara Biochem Lab Inc Production of l-galactose

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 107, no. 3, 20 July 1987, Columbus, Ohio, US; abstract no. 18593H, LEE ET AL.: "The organization of the araBAD operon of escherichia coli" page 162; XP002940777 *
CHEMICAL ABSTRACTS, vol. 121, no. 11, 12 September 1994, Columbus, Ohio, US; abstract no. 132405N, IKUMOR ET AL.: "Manufacture of L-galactose with D-arabinose isomerase" page 878; XP002940779 *
CHEMICAL ABSTRACTS, vol. 129, no. 19, 9 November 1998, Columbus, Ohio, US; abstract no. 244169K, OIH ET AL.: "Optimization of culture conditions for D-gatatose production from D-galactose by enterobacter agglomerans" page 596; XP002940778 *
GENE, vol. 47, no. 2-3, 1986, (ENG.), pages 231 - 244 *
SANOP MISAENGMUL HAKHOECHI, vol. 26, no. 3, 1998, (KORICAN), pages 250 - 260 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002052021A1 (en) * 2000-12-22 2002-07-04 Yu Ryang Pyun Thermostable l-arabinose isomerase and process for preparing d-tagatose thereby
WO2003008593A3 (en) * 2001-07-16 2003-10-30 Bioteknologisk Inst A thermostable isomerase and use thereof in particular for producing tagatose
US7052898B2 (en) 2001-07-16 2006-05-30 Bioneer A/S Thermostable isomerase and use hereof, in particular for producing tagatose
EP2348107A2 (en) 2003-02-18 2011-07-27 Metabolic Explorer Method for preparing evolved micro-organisms, enabling the creation or modification of metabolic pathways
US10570467B1 (en) 2016-09-27 2020-02-25 The Board Of Trustees Of The University Of Illinois Recombinant microorganisms for conversion of oligosaccharides into functional sweeteners
EP3578651A4 (en) * 2016-12-23 2021-01-13 Kyungpook National University Industry-Academic Cooperation Foundation Recombinant strain having modified sugar metabolic pathway and method for screening sugar isomerase using same

Also Published As

Publication number Publication date
EP1095153A1 (en) 2001-05-02
KR100309327B1 (en) 2001-09-29
KR20000073075A (en) 2000-12-05
AU1080600A (en) 2000-11-21

Similar Documents

Publication Publication Date Title
US8216818B2 (en) Ketose 3-epimerase, its preparation and uses
CA2653028C (en) Method for the enzymatic production of 2-hydroxy-2-methyl carboxylic acids
TWI682998B (en) A composition for producing tagatose and methods for producing tagatose using the same
CN105164255B (en) The epimerase mutant of D psicoses 3, recombinant vector and microorganism, the method and reactor for producing D psicoses
JP2020511986A (en) Composition for producing tagatose and method for producing tagatose using the same
JP2020511974A (en) Composition for producing tagatose and method for producing tagatose using the same
CN112831489B (en) Psicose 3-epimerase immobilized enzyme, and immobilization method and application thereof
EP1095153A1 (en) Biological tagatose production by recombinant escherichia coli
USRE29692E (en) Process of preparing glucose isomerase
KR102044957B1 (en) Method for producing psicose using the same
US8852891B2 (en) N-acetylglucosamine-2-epimerase and method for producing CMP-neuraminic acid using the same
JP2000295994A (en) Production of xylitol
EP0251489A2 (en) Process for producing 5'-guanylic acid
US20030235894A1 (en) Biological tagatose production by recombinant Escherichia coli
WO2002072841A1 (en) Dna encoding hydantoinase, dna encoding n-carbamyl-l-amino acid hydrolase, recombinant dna, transformed cells, process for producing protein and process for producing optically active amino acid
CN115261350B (en) Mutant of amylosucrase and application of mutant in production of alpha-arbutin
JPH08263A (en) Recombination enzyme for converting maltose into trehalose
WO2005047510A1 (en) A noble geobacillus thermodenitrificans cbg-a1 strain expressing thermostable l-arabinose isomerase activity, the said enzyme and tagatose-production method
US20250382643A1 (en) GENETICALLY MODIFIED MICROORGANISM FOR PRODUCING 3-HYDROXYADIPIC ACID AND/OR Alpha-HYDROXYADIPIC ACID, AND METHOD FOR PRODUCING CHEMICAL PRODUCT
KR100464061B1 (en) Tagatose production method by immobilization of arabinose isomerase
KR100821377B1 (en) Novel Geobacillus D. Modinitripicus CBG-Al Strain with Heat-Resistant Arabinos Isomerase Activity, Its Enzyme and Tagatose Production Method
CN119177204B (en) Genetically engineered Escherichia coli producing hyaluronic acid, construction method and application thereof
EP1121446A1 (en) Aminoacylase and its use in the production of d-aminoacids
CN113957065B (en) Sucrose isomerase with high conversion rate and application thereof
CN114134136B (en) A rapid preparation method of isomaltulose and its sucrose isomerase at high reaction concentration

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 09743196

Country of ref document: US

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1999954465

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999954465

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1999954465

Country of ref document: EP